Search

everythinglearnresearchcommunity

for

Search:↓

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

Genetic variations affect dutasteride treatment response for male pattern hair loss.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

Ritlecitinib significantly improves scalp hair regrowth in alopecia areata patients over time.

Researchers created a new tool to measure the effects of alopecia areata from the patient's view, focusing on hair loss, daily life, and emotional health.

VILLIN4 helps root hair growth by organizing actin with calcium.

Baricitinib maintains significant hair regrowth in severe alopecia areata over three years.

Deuruxolitinib is approved to treat severe alopecia areata in adults.

IL-4 gene variation may increase the risk of alopecia areata in Turkish people.

Inhibiting ornithine decarboxylase may help prevent certain skin cancers.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

High-throughput LC-MS screening is effective for finding new autotaxin inhibitors for asthma treatment.

Alopecia Areata severely impacts mental health, causing anxiety and depression, affecting quality of life.

Dutasteride is more effective than finasteride in reducing urinary retention and surgery risks in people aged 65 and older.

miR-200c-3p could help diagnose and treat alopecia areata.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

150 kHz electromagnetic radiation might help improve PCOS in rats.

ROOT HAIR SPECIFIC 10 (RHS10) reduces the length of root hairs in Arabidopsis plants.

Baricitinib helps regrow hair and improves quality of life and mental health in severe alopecia areata patients.

Abrocitinib at 100 mg and 200 mg daily may significantly improve moderate-to-severe atopic dermatitis in patients 12 years and older.

A new test helps find drugs to treat head and neck cancer by targeting c-Rel.

The EQ-5D-5L tool may not accurately measure the impact of alopecia areata on patients' lives.

The SAALIQ is a reliable tool for measuring the impact of alopecia areata on Spanish-speaking patients' quality of life.

Certain amino acids in 5AR1 and 5AR2 are crucial for binding and resistance to Finasteride.

Rivaroxaban may cause hair loss.